| 0 |
INSTILLATION SITE REACTION |
1019 |
0.9349 |
| 1 |
INSTILLATION SITE LACRIMATION |
179 |
0.7397 |
| 2 |
INSTILLATION SITE INFLAMMATION |
33 |
0.5893 |
| 3 |
INSTILLATION SITE HYPERSENSITIVITY |
13 |
0.5652 |
| 4 |
INSTILLATION SITE BURN |
24 |
0.5581 |
| 5 |
INSTILLATION SITE PAIN |
1283 |
0.5173 |
| 6 |
INSTILLATION SITE DISCOMFORT |
68 |
0.5075 |
| 7 |
INSTILLATION SITE PRURITUS |
189 |
0.5013 |
| 8 |
INSTILLATION SITE RASH |
6 |
0.4615 |
| 9 |
INSTILLATION SITE DISCHARGE |
118 |
0.4487 |
| 10 |
INSTILLATION SITE SWELLING |
76 |
0.4343 |
| 11 |
INSTILLATION SITE ERYTHEMA |
210 |
0.3977 |
| 12 |
INSTILLATION SITE DRYNESS |
47 |
0.3643 |
| 13 |
INSTILLATION SITE FOREIGN BODY SENSATION |
39 |
0.2690 |
| 14 |
INSTILLATION SITE PARAESTHESIA |
10 |
0.2381 |
| 15 |
INSTILLATION SITE VESICLES |
4 |
0.2353 |
| 16 |
INSTILLATION SITE IRRITATION |
248 |
0.2095 |
| 17 |
INSTILLATION SITE INFECTION |
9 |
0.1915 |
| 18 |
INSTILLATION SITE COMPLICATION |
4 |
0.1905 |
| 19 |
VITAL DYE STAINING CORNEA PRESENT |
6 |
0.1765 |
| 20 |
INSTILLATION SITE HAEMORRHAGE |
6 |
0.1538 |
| 21 |
PRODUCT AFTER TASTE |
73 |
0.0765 |
| 22 |
BLOOD FOLATE DECREASED |
44 |
0.0605 |
| 23 |
DEAFNESS PERMANENT |
11 |
0.0561 |
| 24 |
PERIORBITAL PAIN |
46 |
0.0543 |
| 25 |
EYE IRRITATION |
2780 |
0.0482 |
| 26 |
EYELID MARGIN CRUSTING |
134 |
0.0463 |
| 27 |
SUPERFICIAL INJURY OF EYE |
50 |
0.0457 |
| 28 |
DACRYOCYSTITIS |
7 |
0.0455 |
| 29 |
THERMAL BURNS OF EYE |
9 |
0.0398 |
| 30 |
EYE DISCHARGE |
403 |
0.0387 |
| 31 |
SWOLLEN TEAR DUCT |
4 |
0.0377 |
| 32 |
EYELID PAIN |
76 |
0.0374 |
| 33 |
EYE PARAESTHESIA |
5 |
0.0318 |
| 34 |
PRODUCT CONTAINER ISSUE |
271 |
0.0316 |
| 35 |
CORNEAL DEFECT |
4 |
0.0303 |
| 36 |
LACRIMATION DECREASED |
14 |
0.0295 |
| 37 |
FOREIGN BODY SENSATION IN EYES |
188 |
0.0295 |
| 38 |
CORNEAL EXFOLIATION |
3 |
0.0294 |
| 39 |
EYELASH CHANGES |
5 |
0.0282 |
| 40 |
DACRYOSTENOSIS ACQUIRED |
35 |
0.0271 |
| 41 |
EYE PAIN |
1460 |
0.0259 |
| 42 |
OCULAR ROSACEA |
5 |
0.0246 |
| 43 |
MEIBOMIAN GLAND DYSFUNCTION |
11 |
0.0243 |
| 44 |
PRODUCT DELIVERY MECHANISM ISSUE |
130 |
0.0242 |
| 45 |
PRODUCT USE COMPLAINT |
376 |
0.0238 |
| 46 |
DRY EYE |
1187 |
0.0238 |
| 47 |
OCULAR DISCOMFORT |
261 |
0.0232 |
| 48 |
CORNEAL LESION |
7 |
0.0227 |
| 49 |
CORNEAL ABRASION |
31 |
0.0226 |
| 50 |
EYELID RASH |
22 |
0.0225 |
| 51 |
EYE COMPLICATION ASSOCIATED WITH DEVICE |
6 |
0.0223 |
| 52 |
ULCERATIVE KERATITIS |
60 |
0.0219 |
| 53 |
CORNEAL SCAR |
11 |
0.0219 |
| 54 |
CHALAZION |
14 |
0.0218 |
| 55 |
CORNEAL REFLEX DECREASED |
8 |
0.0213 |
| 56 |
EYELID IRRITATION |
53 |
0.0211 |
| 57 |
LACRIMATION INCREASED |
636 |
0.0210 |
| 58 |
EYE ULCER |
12 |
0.0208 |
| 59 |
PATIENT DISSATISFACTION WITH TREATMENT |
40 |
0.0207 |
| 60 |
PUNCTATE KERATITIS |
19 |
0.0207 |
| 61 |
DERMATOCHALASIS |
3 |
0.0204 |
| 62 |
PRODUCT DESIGN ISSUE |
14 |
0.0196 |
| 63 |
VISION BLURRED |
2679 |
0.0195 |
| 64 |
PRODUCT KNOWLEDGE DEFICIT |
15 |
0.0192 |
| 65 |
CORNEAL DYSTROPHY |
8 |
0.0191 |
| 66 |
LACRIMAL DISORDER |
11 |
0.0189 |
| 67 |
PACKAGING DESIGN ISSUE |
6 |
0.0182 |
| 68 |
EYELID EXFOLIATION |
14 |
0.0177 |
| 69 |
EYELID THICKENING |
5 |
0.0175 |
| 70 |
ENDOCRINE OPHTHALMOPATHY |
15 |
0.0173 |
| 71 |
ABNORMAL SENSATION IN EYE |
74 |
0.0172 |
| 72 |
CORNEAL EROSION |
9 |
0.0167 |
| 73 |
FOREIGN BODY IN EYE |
16 |
0.0167 |
| 74 |
DYSGEUSIA |
1118 |
0.0150 |
| 75 |
OCULAR HYPERAEMIA |
707 |
0.0149 |
| 76 |
PERIORBITAL IRRITATION |
5 |
0.0146 |
| 77 |
TEMPOROMANDIBULAR PAIN AND DYSFUNCTION SYNDROME |
6 |
0.0141 |
| 78 |
EYELID DISORDER |
32 |
0.0139 |
| 79 |
SWELLING OF EYELID |
87 |
0.0138 |
| 80 |
GLARE |
7 |
0.0136 |
| 81 |
INJURY CORNEAL |
7 |
0.0135 |
| 82 |
EYE PRURITUS |
446 |
0.0133 |
| 83 |
GRAFT VERSUS HOST DISEASE IN EYE |
3 |
0.0130 |
| 84 |
ERYTHEMA OF EYELID |
69 |
0.0127 |
| 85 |
PERIORBITAL SWELLING |
72 |
0.0127 |
| 86 |
BLEPHARITIS |
51 |
0.0127 |
| 87 |
EYE INJURY |
38 |
0.0125 |
| 88 |
CORNEAL DEGENERATION |
3 |
0.0124 |
| 89 |
CENTRAL SLEEP APNOEA SYNDROME |
4 |
0.0123 |
| 90 |
EUSTACHIAN TUBE DYSFUNCTION |
7 |
0.0122 |
| 91 |
ASTHENOPIA |
66 |
0.0120 |
| 92 |
CORNEAL DISORDER |
26 |
0.0118 |
| 93 |
CORNEAL THINNING |
3 |
0.0117 |
| 94 |
CONJUNCTIVAL OEDEMA |
12 |
0.0117 |
| 95 |
POSTERIOR CAPSULE OPACIFICATION |
4 |
0.0117 |
| 96 |
SINUS PAIN |
27 |
0.0116 |
| 97 |
PRODUCT DROPPER ISSUE |
9 |
0.0114 |
| 98 |
EYELID OPERATION |
3 |
0.0112 |
| 99 |
EPIRETINAL MEMBRANE |
3 |
0.0108 |
| 100 |
PRODUCT CLOSURE REMOVAL DIFFICULT |
11 |
0.0108 |
| 101 |
DENTAL PLAQUE |
3 |
0.0108 |
| 102 |
OPHTHALMIC HERPES SIMPLEX |
6 |
0.0104 |
| 103 |
EYE DISORDER |
338 |
0.0103 |
| 104 |
PHOTOPHOBIA |
188 |
0.0100 |
| 105 |
EYELID SKIN DRYNESS |
12 |
0.0099 |
| 106 |
EYE COLOUR CHANGE |
10 |
0.0098 |
| 107 |
LAGOPHTHALMOS |
4 |
0.0098 |
| 108 |
TASTE DISORDER |
195 |
0.0096 |
| 109 |
WRONG DOSE |
23 |
0.0095 |
| 110 |
PERIORBITAL CELLULITIS |
5 |
0.0093 |
| 111 |
PRESBYOPIA |
5 |
0.0090 |
| 112 |
PRODUCT CLOSURE ISSUE |
5 |
0.0090 |
| 113 |
EYE INFECTION BACTERIAL |
5 |
0.0090 |
| 114 |
ECTROPION |
3 |
0.0089 |
| 115 |
PRODUCT PACKAGING DIFFICULT TO OPEN |
23 |
0.0088 |
| 116 |
EYE INFECTION |
99 |
0.0088 |
| 117 |
EYE INFLAMMATION |
83 |
0.0087 |
| 118 |
EYELIDS PRURITUS |
27 |
0.0087 |
| 119 |
HORDEOLUM |
37 |
0.0085 |
| 120 |
GASTROINTESTINAL MICROORGANISM OVERGROWTH |
3 |
0.0085 |
| 121 |
EYE BURNS |
5 |
0.0085 |
| 122 |
EYE ALLERGY |
13 |
0.0084 |
| 123 |
METAMORPHOPSIA |
15 |
0.0081 |
| 124 |
EXCESSIVE EYE BLINKING |
12 |
0.0081 |
| 125 |
CONJUNCTIVITIS ALLERGIC |
12 |
0.0081 |
| 126 |
EYE SWELLING |
283 |
0.0076 |
| 127 |
EYELID FUNCTION DISORDER |
6 |
0.0076 |
| 128 |
PRODUCT CONTAINER SEAL ISSUE |
13 |
0.0075 |
| 129 |
KERATITIS |
22 |
0.0072 |
| 130 |
INTRAOCULAR PRESSURE TEST ABNORMAL |
5 |
0.0071 |
| 131 |
HALO VISION |
8 |
0.0071 |
| 132 |
HEARING AID USER |
3 |
0.0070 |
| 133 |
HYPOAESTHESIA EYE |
4 |
0.0068 |
| 134 |
PRODUCT RESIDUE PRESENT |
36 |
0.0067 |
| 135 |
APPENDIX DISORDER |
9 |
0.0064 |
| 136 |
CORNEAL PERFORATION |
4 |
0.0063 |
| 137 |
PRODUCT DISPENSING ISSUE |
27 |
0.0063 |
| 138 |
INABILITY TO AFFORD MEDICATION |
62 |
0.0062 |
| 139 |
PRODUCT PACKAGING ISSUE |
59 |
0.0062 |
| 140 |
RHINALGIA |
17 |
0.0062 |
| 141 |
SCLERAL DISCOLOURATION |
4 |
0.0061 |
| 142 |
UPPER-AIRWAY COUGH SYNDROME |
50 |
0.0061 |
| 143 |
CATARACT NUCLEAR |
4 |
0.0060 |
| 144 |
PRODUCT TASTE ABNORMAL |
77 |
0.0057 |
| 145 |
BLINDNESS TRANSIENT |
41 |
0.0056 |
| 146 |
FRUSTRATION TOLERANCE DECREASED |
44 |
0.0054 |
| 147 |
DRY AGE-RELATED MACULAR DEGENERATION |
6 |
0.0054 |
| 148 |
BUNION OPERATION |
3 |
0.0053 |
| 149 |
LIQUID PRODUCT PHYSICAL ISSUE |
39 |
0.0053 |
| 150 |
INCREASED VISCOSITY OF UPPER RESPIRATORY SECRETION |
4 |
0.0052 |
| 151 |
CORNEAL EPITHELIUM DEFECT |
3 |
0.0052 |
| 152 |
CONJUNCTIVAL HYPERAEMIA |
18 |
0.0050 |
| 153 |
NEOVASCULAR AGE-RELATED MACULAR DEGENERATION |
7 |
0.0050 |
| 154 |
CONJUNCTIVAL HAEMORRHAGE |
19 |
0.0050 |
| 155 |
SUSPECTED PRODUCT CONTAMINATION |
5 |
0.0049 |
| 156 |
ARTHROPOD STING |
8 |
0.0048 |
| 157 |
VISUAL IMPAIRMENT |
587 |
0.0047 |
| 158 |
EYE CONTUSION |
10 |
0.0047 |
| 159 |
NASAL DISCOMFORT |
37 |
0.0047 |
| 160 |
HERPES OPHTHALMIC |
6 |
0.0045 |
| 161 |
BURNING SENSATION |
317 |
0.0045 |
| 162 |
ALLERGIC REACTION TO EXCIPIENT |
9 |
0.0045 |
| 163 |
PRODUCT OUTER PACKAGING ISSUE |
4 |
0.0044 |
| 164 |
EYE HAEMORRHAGE |
59 |
0.0044 |
| 165 |
INCORRECT DOSE ADMINISTERED BY PRODUCT |
7 |
0.0044 |
| 166 |
NASAL DISCHARGE DISCOLOURATION |
6 |
0.0043 |
| 167 |
PRODUCT EXPIRATION DATE ISSUE |
6 |
0.0043 |
| 168 |
MAST CELL ACTIVATION SYNDROME |
6 |
0.0043 |
| 169 |
MULTIPLE USE OF SINGLE-USE PRODUCT |
24 |
0.0043 |
| 170 |
GLASSY EYES |
3 |
0.0042 |
| 171 |
PARANASAL SINUS DISCOMFORT |
16 |
0.0042 |
| 172 |
HYPERMETROPIA |
4 |
0.0042 |
| 173 |
VITREOUS FLOATERS |
41 |
0.0042 |
| 174 |
MADAROSIS |
48 |
0.0041 |
| 175 |
TREATMENT DELAYED |
7 |
0.0040 |
| 176 |
PRODUCT PACKAGE ASSOCIATED INJURY |
9 |
0.0040 |
| 177 |
CORNEAL DEPOSITS |
3 |
0.0040 |
| 178 |
NASAL OEDEMA |
7 |
0.0039 |
| 179 |
SLEEP DEFICIT |
8 |
0.0038 |
| 180 |
SINUS DISORDER |
73 |
0.0037 |
| 181 |
PRODUCT LABEL ISSUE |
25 |
0.0037 |
| 182 |
CORNEAL OPACITY |
5 |
0.0037 |
| 183 |
BALANOPOSTHITIS |
3 |
0.0036 |
| 184 |
DEAFNESS NEUROSENSORY |
12 |
0.0036 |
| 185 |
MACULAR DEGENERATION |
43 |
0.0036 |
| 186 |
READING DISORDER |
8 |
0.0035 |
| 187 |
PORPHYRIA ACUTE |
5 |
0.0035 |
| 188 |
LUMBAR RADICULOPATHY |
4 |
0.0035 |
| 189 |
GLAUCOMA |
65 |
0.0034 |
| 190 |
OPHTHALMIC HERPES ZOSTER |
6 |
0.0033 |
| 191 |
CERUMEN IMPACTION |
3 |
0.0033 |
| 192 |
RETINAL TEAR |
8 |
0.0032 |
| 193 |
OROPHARYNGEAL DISCOMFORT |
29 |
0.0032 |
| 194 |
PRODUCT DEPOSIT |
5 |
0.0032 |
| 195 |
HYPERAEMIA |
6 |
0.0030 |
| 196 |
EYE OPERATION |
14 |
0.0030 |
| 197 |
CONJUNCTIVITIS |
56 |
0.0030 |
| 198 |
BLINDNESS |
122 |
0.0030 |
| 199 |
EAR HAEMORRHAGE |
6 |
0.0030 |
| 200 |
MYOPIA |
7 |
0.0029 |
| 201 |
DISCHARGE |
4 |
0.0029 |
| 202 |
EYELID OEDEMA |
33 |
0.0028 |
| 203 |
AUDITORY DISORDER |
4 |
0.0028 |
| 204 |
CONNECTIVE TISSUE DISORDER |
4 |
0.0028 |
| 205 |
EXPOSURE VIA SKIN CONTACT |
71 |
0.0027 |
| 206 |
PRODUCT QUALITY ISSUE |
371 |
0.0027 |
| 207 |
PRODUCT ADMINISTRATION ERROR |
55 |
0.0027 |
| 208 |
PRODUCT PHYSICAL CONSISTENCY ISSUE |
15 |
0.0027 |
| 209 |
CORNEAL OEDEMA |
6 |
0.0027 |
| 210 |
PAROSMIA |
20 |
0.0026 |
| 211 |
ASTIGMATISM |
4 |
0.0026 |
| 212 |
CARBON DIOXIDE DECREASED |
3 |
0.0026 |
| 213 |
CHEMICAL BURN |
3 |
0.0026 |
| 214 |
HYPOACUSIS |
112 |
0.0026 |
| 215 |
TONGUE DISCOMFORT |
11 |
0.0026 |
| 216 |
ORAL MUCOSAL ERYTHEMA |
4 |
0.0026 |
| 217 |
SECRETION DISCHARGE |
32 |
0.0026 |
| 218 |
BLEPHAROSPASM |
16 |
0.0025 |
| 219 |
THROAT IRRITATION |
114 |
0.0025 |
| 220 |
PHARYNGEAL PARAESTHESIA |
4 |
0.0025 |
| 221 |
NIGHT BLINDNESS |
4 |
0.0025 |
| 222 |
PHYSICAL DISABILITY |
11 |
0.0025 |
| 223 |
EYE OEDEMA |
6 |
0.0024 |
| 224 |
SHOULDER FRACTURE |
4 |
0.0024 |
| 225 |
EXPIRED PRODUCT ADMINISTERED |
81 |
0.0024 |
| 226 |
EAR DISCOMFORT |
25 |
0.0024 |
| 227 |
STRABISMUS |
7 |
0.0024 |
| 228 |
CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR |
80 |
0.0024 |
| 229 |
CATARACT OPERATION |
14 |
0.0024 |
| 230 |
SINUS HEADACHE |
14 |
0.0024 |
| 231 |
APPLICATION SITE WARMTH |
3 |
0.0024 |
| 232 |
PRODUCT COLOUR ISSUE |
12 |
0.0023 |
| 233 |
EXOPHTHALMOS |
5 |
0.0023 |
| 234 |
ACUTE SINUSITIS |
4 |
0.0023 |
| 235 |
RECALLED PRODUCT |
4 |
0.0023 |
| 236 |
PRODUCT ADMINISTRATION INTERRUPTED |
18 |
0.0023 |
| 237 |
INFUSION SITE DISCHARGE |
4 |
0.0023 |
| 238 |
OESOPHAGEAL PAIN |
9 |
0.0023 |
| 239 |
ACROCHORDON |
3 |
0.0023 |
| 240 |
AUTOIMMUNE DISORDER |
22 |
0.0023 |
| 241 |
TEMPOROMANDIBULAR JOINT SYNDROME |
6 |
0.0022 |
| 242 |
FACIAL PAIN |
20 |
0.0022 |
| 243 |
PRODUCT AVAILABILITY ISSUE |
51 |
0.0022 |
| 244 |
NASAL DRYNESS |
14 |
0.0022 |
| 245 |
VISUAL ACUITY REDUCED |
74 |
0.0022 |
| 246 |
PHOTOPSIA |
14 |
0.0022 |
| 247 |
CARBON DIOXIDE INCREASED |
3 |
0.0022 |
| 248 |
THERAPEUTIC PRODUCT EFFECT DELAYED |
10 |
0.0022 |
| 249 |
CUTANEOUS VASCULITIS |
8 |
0.0022 |
| 250 |
MEAN CELL HAEMOGLOBIN DECREASED |
4 |
0.0022 |
| 251 |
DRY THROAT |
22 |
0.0022 |
| 252 |
CATARACT |
128 |
0.0021 |
| 253 |
PRODUCT COMPLAINT |
54 |
0.0021 |
| 254 |
WHITE BLOOD CELLS URINE POSITIVE |
4 |
0.0021 |
| 255 |
INTRAOCULAR PRESSURE INCREASED |
27 |
0.0021 |
| 256 |
FACE INJURY |
8 |
0.0021 |
| 257 |
PARANASAL SINUS HYPERSECRETION |
8 |
0.0021 |
| 258 |
INSURANCE ISSUE |
32 |
0.0021 |
| 259 |
GINGIVAL RECESSION |
4 |
0.0021 |
| 260 |
HYPOTHALAMO-PITUITARY DISORDER |
3 |
0.0021 |
| 261 |
OCULAR HYPERTENSION |
4 |
0.0021 |
| 262 |
BLINDNESS UNILATERAL |
29 |
0.0021 |
| 263 |
NASAL SEPTUM DEVIATION |
4 |
0.0020 |
| 264 |
HYPERSENSITIVITY |
379 |
0.0020 |
| 265 |
DARK CIRCLES UNDER EYES |
3 |
0.0020 |
| 266 |
VOCAL CORD DISORDER |
4 |
0.0020 |
| 267 |
IMPAIRED DRIVING ABILITY |
23 |
0.0020 |
| 268 |
ADHESION |
3 |
0.0020 |
| 269 |
ARTHRITIS |
156 |
0.0020 |
| 270 |
SINUSITIS |
201 |
0.0020 |
| 271 |
PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION |
12 |
0.0019 |
| 272 |
ROSACEA |
9 |
0.0019 |
| 273 |
DERMATITIS CONTACT |
22 |
0.0019 |
| 274 |
RETINAL DISORDER |
5 |
0.0019 |
| 275 |
PRODUCT DOSE OMISSION |
125 |
0.0019 |
| 276 |
EAR SWELLING |
4 |
0.0019 |
| 277 |
VITREOUS DETACHMENT |
4 |
0.0018 |
| 278 |
AGEUSIA |
46 |
0.0018 |
| 279 |
CHAPPED LIPS |
8 |
0.0018 |
| 280 |
PHARYNGEAL SWELLING |
18 |
0.0018 |
| 281 |
PRODUCT DOSE OMISSION IN ERROR |
52 |
0.0018 |
| 282 |
SNEEZING |
41 |
0.0018 |
| 283 |
MIDDLE EAR EFFUSION |
4 |
0.0018 |
| 284 |
PRODUCT LOT NUMBER ISSUE |
4 |
0.0018 |
| 285 |
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION |
127 |
0.0018 |
| 286 |
PIGMENTATION DISORDER |
11 |
0.0018 |
| 287 |
DIPLOPIA |
46 |
0.0018 |
| 288 |
SEASONAL ALLERGY |
25 |
0.0018 |
| 289 |
DRUG EFFECT DELAYED |
8 |
0.0018 |
| 290 |
EYE MOVEMENT DISORDER |
12 |
0.0018 |
| 291 |
PRODUCT TEMPERATURE EXCURSION ISSUE |
9 |
0.0017 |
| 292 |
ORAL PRURITUS |
4 |
0.0017 |
| 293 |
RESPIRATORY TRACT INFECTION VIRAL |
4 |
0.0017 |
| 294 |
RHINORRHOEA |
111 |
0.0017 |
| 295 |
SPINAL STENOSIS |
7 |
0.0017 |
| 296 |
MACULOPATHY |
6 |
0.0017 |
| 297 |
FOOD ALLERGY |
13 |
0.0017 |
| 298 |
IMPAIRED QUALITY OF LIFE |
24 |
0.0017 |
| 299 |
APHONIA |
23 |
0.0016 |
| 300 |
PURULENT DISCHARGE |
7 |
0.0016 |
| 301 |
INCORRECT DOSAGE ADMINISTERED |
8 |
0.0016 |
| 302 |
BODY TEMPERATURE ABNORMAL |
3 |
0.0016 |
| 303 |
SINUS CONGESTION |
22 |
0.0016 |
| 304 |
DENTAL CARE |
3 |
0.0016 |
| 305 |
ACCIDENTAL EXPOSURE TO PRODUCT |
167 |
0.0016 |
| 306 |
CONCOMITANT DISEASE AGGRAVATED |
10 |
0.0016 |
| 307 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
287 |
0.0016 |
| 308 |
CYSTOID MACULAR OEDEMA |
3 |
0.0016 |
| 309 |
PRODUCT PRESCRIBING ISSUE |
34 |
0.0016 |
| 310 |
MEAN CELL VOLUME INCREASED |
4 |
0.0016 |
| 311 |
MENOPAUSE |
4 |
0.0016 |
| 312 |
THERMAL BURN |
11 |
0.0015 |
| 313 |
PRODUCT DOSE OMISSION ISSUE |
454 |
0.0015 |
| 314 |
PRODUCT SUPPLY ISSUE |
11 |
0.0015 |
| 315 |
HYPOGEUSIA |
3 |
0.0015 |
| 316 |
EAR DISORDER |
7 |
0.0015 |
| 317 |
DRUG DELIVERY SYSTEM ISSUE |
3 |
0.0015 |
| 318 |
ADVERSE REACTION |
20 |
0.0015 |
| 319 |
BLOOD POTASSIUM ABNORMAL |
4 |
0.0015 |
| 320 |
SKIN DISCOMFORT |
4 |
0.0015 |
| 321 |
DISCOMFORT |
90 |
0.0015 |
| 322 |
VIRAL UPPER RESPIRATORY TRACT INFECTION |
7 |
0.0015 |
| 323 |
DRY MOUTH |
117 |
0.0014 |
| 324 |
TRICHORRHEXIS |
4 |
0.0014 |
| 325 |
INFUSION SITE SWELLING |
9 |
0.0014 |
| 326 |
PRODUCT CONTAMINATION |
5 |
0.0014 |
| 327 |
MULTIPLE ALLERGIES |
11 |
0.0014 |
| 328 |
MYDRIASIS |
18 |
0.0014 |
| 329 |
LIP PAIN |
4 |
0.0014 |
| 330 |
PHOTOSENSITIVITY REACTION |
23 |
0.0014 |
| 331 |
BONE LESION |
5 |
0.0014 |
| 332 |
OROPHARYNGEAL PAIN |
128 |
0.0014 |
| 333 |
FINE MOTOR SKILL DYSFUNCTION |
4 |
0.0014 |
| 334 |
TOOTHACHE |
25 |
0.0014 |
| 335 |
SWOLLEN TONGUE |
43 |
0.0014 |
| 336 |
WRONG PATIENT RECEIVED PRODUCT |
4 |
0.0014 |
| 337 |
PRODUCT COMMUNICATION ISSUE |
12 |
0.0014 |
| 338 |
DRUG EFFECT LESS THAN EXPECTED |
20 |
0.0013 |
| 339 |
RHINITIS ALLERGIC |
6 |
0.0013 |
| 340 |
TENDON INJURY |
5 |
0.0013 |
| 341 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
271 |
0.0013 |
| 342 |
ILLNESS |
137 |
0.0013 |
| 343 |
HYPOAESTHESIA ORAL |
20 |
0.0013 |
| 344 |
IRITIS |
4 |
0.0013 |
| 345 |
SENSATION OF FOREIGN BODY |
11 |
0.0013 |
| 346 |
ORAL DISCOMFORT |
18 |
0.0013 |
| 347 |
INFUSION SITE PRURITUS |
4 |
0.0013 |
| 348 |
IRIDOCYCLITIS |
4 |
0.0013 |
| 349 |
OESOPHAGEAL CANDIDIASIS |
5 |
0.0013 |
| 350 |
ILL-DEFINED DISORDER |
76 |
0.0012 |
| 351 |
PRODUCT STORAGE ERROR |
109 |
0.0012 |
| 352 |
ANOSMIA |
18 |
0.0012 |
| 353 |
DRUG INEFFECTIVE |
1629 |
0.0012 |
| 354 |
POOR QUALITY PRODUCT ADMINISTERED |
13 |
0.0012 |
| 355 |
BREATH ODOUR |
3 |
0.0012 |
| 356 |
TRIGGER FINGER |
5 |
0.0012 |
| 357 |
INCORRECT PRODUCT STORAGE |
16 |
0.0012 |
| 358 |
BLOOD IMMUNOGLOBULIN G DECREASED |
3 |
0.0012 |
| 359 |
PRODUCT USE ISSUE |
226 |
0.0012 |
| 360 |
DEVICE USE ISSUE |
21 |
0.0012 |
| 361 |
RETINAL DETACHMENT |
11 |
0.0012 |
| 362 |
BACK INJURY |
13 |
0.0012 |
| 363 |
DEAFNESS |
31 |
0.0012 |
| 364 |
DERMATOMYOSITIS |
3 |
0.0012 |
| 365 |
EAR PAIN |
23 |
0.0012 |
| 366 |
LIP SWELLING |
39 |
0.0012 |
| 367 |
SPUTUM DISCOLOURED |
11 |
0.0012 |
| 368 |
SPINAL OSTEOARTHRITIS |
10 |
0.0011 |
| 369 |
TINNITUS |
52 |
0.0011 |
| 370 |
DRUG INTOLERANCE |
109 |
0.0011 |
| 371 |
PRE-EXISTING CONDITION IMPROVED |
7 |
0.0011 |
| 372 |
THERAPEUTIC RESPONSE UNEXPECTED |
50 |
0.0011 |
| 373 |
FACIAL BONES FRACTURE |
4 |
0.0011 |
| 374 |
PARAESTHESIA ORAL |
16 |
0.0011 |
| 375 |
VISUAL FIELD DEFECT |
8 |
0.0011 |
| 376 |
THERAPY INTERRUPTED |
78 |
0.0011 |
| 377 |
FOOT DEFORMITY |
12 |
0.0011 |
| 378 |
ARTHRITIS INFECTIVE |
5 |
0.0011 |
| 379 |
CARPAL TUNNEL SYNDROME |
15 |
0.0011 |
| 380 |
PRODUCT LEAKAGE |
6 |
0.0011 |
| 381 |
THROAT CLEARING |
4 |
0.0011 |
| 382 |
SNORING |
4 |
0.0011 |
| 383 |
NASAL CONGESTION |
62 |
0.0011 |
| 384 |
INTENTIONAL DOSE OMISSION |
30 |
0.0011 |
| 385 |
HEART VALVE INCOMPETENCE |
3 |
0.0010 |
| 386 |
CLAVICLE FRACTURE |
4 |
0.0010 |
| 387 |
BREAST MASS |
7 |
0.0010 |
| 388 |
BLOOD PARATHYROID HORMONE INCREASED |
3 |
0.0010 |
| 389 |
EPISTAXIS |
77 |
0.0010 |
| 390 |
PELVIC FRACTURE |
8 |
0.0010 |
| 391 |
FORMICATION |
7 |
0.0010 |
| 392 |
ULCER |
16 |
0.0010 |
| 393 |
GINGIVAL PAIN |
8 |
0.0010 |
| 394 |
UPPER LIMB FRACTURE |
20 |
0.0010 |
| 395 |
HEADACHE |
629 |
0.0010 |
| 396 |
THROAT TIGHTNESS |
27 |
0.0010 |
| 397 |
OVERDOSE |
215 |
0.0010 |
| 398 |
CEREBROVASCULAR DISORDER |
3 |
0.0010 |
| 399 |
MIGRAINE |
95 |
0.0010 |
| 400 |
ACCIDENTAL OVERDOSE |
36 |
0.0010 |
| 401 |
SPINAL OPERATION |
12 |
0.0010 |
| 402 |
INTERVERTEBRAL DISC DEGENERATION |
9 |
0.0010 |
| 403 |
SCAB |
11 |
0.0010 |
| 404 |
INFUSION SITE EXTRAVASATION |
6 |
0.0010 |
| 405 |
DISABILITY |
19 |
0.0010 |
| 406 |
BLOOD BLISTER |
3 |
0.0010 |
| 407 |
DYSPHONIA |
56 |
0.0010 |
| 408 |
BRAIN FOG |
15 |
0.0010 |
| 409 |
SURGERY |
56 |
0.0010 |
| 410 |
PRODUCT ODOUR ABNORMAL |
10 |
0.0010 |
| 411 |
LEUKAEMIA |
9 |
0.0010 |
| 412 |
FOREIGN BODY IN THROAT |
3 |
0.0010 |
| 413 |
ABDOMINAL ADHESIONS |
3 |
0.0009 |
| 414 |
ATTENTION DEFICIT HYPERACTIVITY DISORDER |
4 |
0.0009 |
| 415 |
DRUG EFFECT INCREASED |
3 |
0.0009 |
| 416 |
INTENTIONAL PRODUCT USE ISSUE |
83 |
0.0009 |
| 417 |
ORAL PAIN |
21 |
0.0009 |
| 418 |
TENSION HEADACHE |
4 |
0.0009 |
| 419 |
HIP SURGERY |
5 |
0.0009 |
| 420 |
BACK DISORDER |
15 |
0.0009 |
| 421 |
GASTROOESOPHAGEAL REFLUX DISEASE |
74 |
0.0009 |
| 422 |
COVID-19 |
161 |
0.0009 |
| 423 |
LIGAMENT SPRAIN |
9 |
0.0009 |
| 424 |
CONDITION AGGRAVATED |
276 |
0.0009 |
| 425 |
DEAFNESS UNILATERAL |
5 |
0.0009 |
| 426 |
GINGIVAL SWELLING |
4 |
0.0009 |
| 427 |
LIGAMENT RUPTURE |
4 |
0.0009 |
| 428 |
PURPURA |
8 |
0.0009 |
| 429 |
CONCUSSION |
7 |
0.0009 |
| 430 |
SLEEP APNOEA SYNDROME |
17 |
0.0009 |
| 431 |
INCORRECT DOSE ADMINISTERED |
203 |
0.0009 |
| 432 |
CANDIDA INFECTION |
15 |
0.0009 |
| 433 |
EYELID PTOSIS |
9 |
0.0009 |
| 434 |
BLOOD THYROID STIMULATING HORMONE DECREASED |
4 |
0.0009 |
| 435 |
URINE ABNORMALITY |
4 |
0.0009 |
| 436 |
HAEMOGLOBIN INCREASED |
4 |
0.0009 |
| 437 |
MOUTH SWELLING |
5 |
0.0009 |
| 438 |
PRODUCT DISTRIBUTION ISSUE |
8 |
0.0009 |
| 439 |
RENAL FUNCTION TEST ABNORMAL |
4 |
0.0009 |
| 440 |
VASCULITIS |
10 |
0.0009 |
| 441 |
EAR PRURITUS |
3 |
0.0009 |
| 442 |
BONE EROSION |
3 |
0.0008 |
| 443 |
BRADYKINESIA |
5 |
0.0008 |
| 444 |
GLUCOSE TOLERANCE IMPAIRED |
5 |
0.0008 |
| 445 |
FEELING ABNORMAL |
202 |
0.0008 |
| 446 |
ANKLE FRACTURE |
13 |
0.0008 |
| 447 |
LIMB OPERATION |
4 |
0.0008 |
| 448 |
ADVERSE DRUG REACTION |
74 |
0.0008 |
| 449 |
FIBROMYALGIA |
20 |
0.0008 |
| 450 |
FACIAL PARALYSIS |
7 |
0.0008 |
| 451 |
EXTRA DOSE ADMINISTERED |
33 |
0.0008 |
| 452 |
HYSTERECTOMY |
7 |
0.0008 |
| 453 |
GASTROINTESTINAL SOUNDS ABNORMAL |
4 |
0.0008 |
| 454 |
IMPAIRED GASTRIC EMPTYING |
11 |
0.0008 |
| 455 |
SKIN SWELLING |
7 |
0.0008 |
| 456 |
GLOSSODYNIA |
18 |
0.0008 |
| 457 |
OSTEOARTHRITIS |
34 |
0.0008 |
| 458 |
FLUID INTAKE REDUCED |
4 |
0.0008 |
| 459 |
CHRONIC SINUSITIS |
3 |
0.0008 |
| 460 |
TREATMENT FAILURE |
66 |
0.0008 |
| 461 |
DERMATITIS ALLERGIC |
10 |
0.0008 |
| 462 |
SCREAMING |
5 |
0.0008 |
| 463 |
UNEVALUABLE EVENT |
59 |
0.0008 |
| 464 |
INCREASED UPPER AIRWAY SECRETION |
4 |
0.0008 |
| 465 |
INFUSION SITE PAIN |
10 |
0.0008 |
| 466 |
TRISMUS |
4 |
0.0008 |
| 467 |
LIMB INJURY |
21 |
0.0008 |
| 468 |
VERTIGO |
47 |
0.0008 |
| 469 |
PERIORBITAL OEDEMA |
4 |
0.0008 |
| 470 |
POLYP |
5 |
0.0008 |
| 471 |
ORAL CANDIDIASIS |
10 |
0.0008 |
| 472 |
DYSGRAPHIA |
5 |
0.0008 |
| 473 |
NERVE COMPRESSION |
7 |
0.0008 |
| 474 |
APPETITE DISORDER |
5 |
0.0008 |
| 475 |
SCIATICA |
12 |
0.0008 |
| 476 |
JOINT INJURY |
16 |
0.0007 |
| 477 |
POST-TRAUMATIC STRESS DISORDER |
5 |
0.0007 |
| 478 |
RHINITIS |
6 |
0.0007 |
| 479 |
FEAR |
20 |
0.0007 |
| 480 |
MYASTHENIA GRAVIS |
6 |
0.0007 |
| 481 |
UVEITIS |
10 |
0.0007 |
| 482 |
HEAD DISCOMFORT |
13 |
0.0007 |
| 483 |
ABNORMAL LOSS OF WEIGHT |
5 |
0.0007 |
| 484 |
GOITRE |
3 |
0.0007 |
| 485 |
OESOPHAGITIS |
8 |
0.0007 |
| 486 |
NONSPECIFIC REACTION |
4 |
0.0007 |
| 487 |
ECONOMIC PROBLEM |
11 |
0.0007 |
| 488 |
CHOKING SENSATION |
4 |
0.0007 |
| 489 |
SWELLING FACE |
47 |
0.0007 |
| 490 |
NERVE INJURY |
8 |
0.0007 |
| 491 |
EAR INFECTION |
19 |
0.0007 |
| 492 |
SKIN INFECTION |
8 |
0.0007 |
| 493 |
HAND FRACTURE |
5 |
0.0007 |
| 494 |
MUSCULOSKELETAL DISCOMFORT |
12 |
0.0007 |
| 495 |
PRODUCT PHYSICAL ISSUE |
14 |
0.0007 |
| 496 |
THERAPEUTIC RESPONSE SHORTENED |
23 |
0.0007 |
| 497 |
DIVERTICULUM INTESTINAL |
3 |
0.0007 |
| 498 |
HIP FRACTURE |
22 |
0.0007 |
| 499 |
THERAPY CESSATION |
35 |
0.0007 |
| 500 |
DEMENTIA |
19 |
0.0007 |
| 501 |
SKIN IRRITATION |
31 |
0.0007 |
| 502 |
PRODUCT PRESCRIBING ERROR |
16 |
0.0007 |
| 503 |
ODYNOPHAGIA |
4 |
0.0007 |
| 504 |
DERMATITIS |
14 |
0.0007 |
| 505 |
WRIST FRACTURE |
8 |
0.0007 |
| 506 |
STOMATITIS |
40 |
0.0007 |
| 507 |
BLOOD THYROID STIMULATING HORMONE INCREASED |
6 |
0.0007 |
| 508 |
PRESCRIBED UNDERDOSE |
13 |
0.0007 |
| 509 |
BLOOD CHOLESTEROL ABNORMAL |
3 |
0.0006 |
| 510 |
LOW DENSITY LIPOPROTEIN INCREASED |
5 |
0.0006 |
| 511 |
SCOLIOSIS |
4 |
0.0006 |
| 512 |
PHARYNGITIS |
8 |
0.0006 |
| 513 |
BACTERIAL INFECTION |
12 |
0.0006 |
| 514 |
SPINAL DISORDER |
6 |
0.0006 |
| 515 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
45 |
0.0006 |
| 516 |
ABDOMINAL DISCOMFORT |
105 |
0.0006 |
| 517 |
NEURALGIA |
15 |
0.0006 |
| 518 |
SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE |
4 |
0.0006 |
| 519 |
SKIN FISSURES |
12 |
0.0006 |
| 520 |
PLATELET COUNT INCREASED |
8 |
0.0006 |
| 521 |
DYSPEPSIA |
60 |
0.0006 |
| 522 |
NECK PAIN |
34 |
0.0006 |
| 523 |
BLOOD PRESSURE INCREASED |
93 |
0.0006 |
| 524 |
HYPERVOLAEMIA |
3 |
0.0006 |
| 525 |
CORONAVIRUS INFECTION |
4 |
0.0006 |
| 526 |
BRAIN INJURY |
6 |
0.0006 |
| 527 |
INFUSION SITE ERYTHEMA |
5 |
0.0006 |
| 528 |
PAIN |
364 |
0.0006 |
| 529 |
NASOPHARYNGITIS |
109 |
0.0006 |
| 530 |
PSORIATIC ARTHROPATHY |
24 |
0.0006 |
| 531 |
PLATELET COUNT DECREASED |
63 |
0.0006 |
| 532 |
ACCIDENT |
7 |
0.0006 |
| 533 |
PHARYNGEAL OEDEMA |
9 |
0.0006 |
| 534 |
THYROID DISORDER |
9 |
0.0006 |
| 535 |
ONYCHOCLASIS |
4 |
0.0006 |
| 536 |
PRURITUS |
223 |
0.0006 |
| 537 |
FOOT FRACTURE |
11 |
0.0006 |
| 538 |
BLISTER |
32 |
0.0006 |
| 539 |
NEOPLASM MALIGNANT |
38 |
0.0006 |
| 540 |
SCRATCH |
6 |
0.0006 |
| 541 |
BRONCHITIS |
42 |
0.0006 |
| 542 |
SKIN DISCOLOURATION |
26 |
0.0006 |
| 543 |
EATING DISORDER |
12 |
0.0006 |
| 544 |
PALPITATIONS |
66 |
0.0006 |
| 545 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
27 |
0.0006 |
| 546 |
BODY HEIGHT DECREASED |
6 |
0.0006 |
| 547 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
25 |
0.0006 |
| 548 |
DIZZINESS |
278 |
0.0006 |
| 549 |
ANAL INCONTINENCE |
5 |
0.0006 |
| 550 |
NERVOUSNESS |
29 |
0.0006 |
| 551 |
ERYTHEMA |
114 |
0.0006 |
| 552 |
PHARYNGITIS STREPTOCOCCAL |
6 |
0.0006 |
| 553 |
BLOOD PRESSURE ABNORMAL |
11 |
0.0006 |
| 554 |
TONGUE DISORDER |
4 |
0.0006 |
| 555 |
NO ADVERSE EVENT |
100 |
0.0006 |
| 556 |
IMPAIRED HEALING |
18 |
0.0005 |
| 557 |
MAJOR DEPRESSION |
4 |
0.0005 |
| 558 |
ROTATOR CUFF SYNDROME |
7 |
0.0005 |
| 559 |
AUTISM SPECTRUM DISORDER |
3 |
0.0005 |
| 560 |
PNEUMONIA BACTERIAL |
5 |
0.0005 |
| 561 |
WHITE BLOOD CELL COUNT DECREASED |
59 |
0.0005 |
| 562 |
BRAIN NEOPLASM |
5 |
0.0005 |
| 563 |
ADVERSE EVENT |
50 |
0.0005 |
| 564 |
INFLAMMATION |
28 |
0.0005 |
| 565 |
COUGH |
152 |
0.0005 |
| 566 |
UPPER RESPIRATORY TRACT INFECTION |
25 |
0.0005 |
| 567 |
CEREBRAL DISORDER |
4 |
0.0005 |
| 568 |
FUNGAL INFECTION |
18 |
0.0005 |
| 569 |
SKIN HAEMORRHAGE |
8 |
0.0005 |
| 570 |
HEPATIC STEATOSIS |
10 |
0.0005 |
| 571 |
SYSTEMIC LUPUS ERYTHEMATOSUS |
19 |
0.0005 |
| 572 |
ANGIOPATHY |
3 |
0.0005 |
| 573 |
RIB FRACTURE |
11 |
0.0005 |
| 574 |
HEART RATE IRREGULAR |
12 |
0.0005 |
| 575 |
BLOOD SODIUM DECREASED |
10 |
0.0005 |
| 576 |
SCAR |
9 |
0.0005 |
| 577 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
9 |
0.0005 |
| 578 |
QUALITY OF LIFE DECREASED |
7 |
0.0005 |
| 579 |
SKIN EXFOLIATION |
44 |
0.0005 |
| 580 |
HERPES VIRUS INFECTION |
3 |
0.0005 |
| 581 |
BALANCE DISORDER |
45 |
0.0005 |
| 582 |
HYPERVENTILATION |
3 |
0.0005 |
| 583 |
APHTHOUS ULCER |
4 |
0.0005 |
| 584 |
IRRITABLE BOWEL SYNDROME |
11 |
0.0005 |
| 585 |
SPINAL PAIN |
6 |
0.0005 |
| 586 |
VIRAL INFECTION |
17 |
0.0005 |
| 587 |
MEMORY IMPAIRMENT |
70 |
0.0005 |
| 588 |
CHEST DISCOMFORT |
52 |
0.0005 |
| 589 |
PRODUCT DISPENSING ERROR |
11 |
0.0005 |
| 590 |
BLADDER DISORDER |
5 |
0.0005 |
| 591 |
RESPIRATORY TRACT CONGESTION |
8 |
0.0005 |
| 592 |
INTENTIONAL PRODUCT MISUSE |
44 |
0.0005 |
| 593 |
ENDOPHTHALMITIS |
3 |
0.0005 |
| 594 |
SENSORY LOSS |
4 |
0.0005 |
| 595 |
LOCALISED INFECTION |
12 |
0.0005 |
| 596 |
PRODUCT ADMINISTERED AT INAPPROPRIATE SITE |
9 |
0.0005 |
| 597 |
URTICARIA |
82 |
0.0005 |
| 598 |
FALL |
161 |
0.0005 |
| 599 |
GASTROINTESTINAL DISORDER |
43 |
0.0005 |
| 600 |
TENDERNESS |
5 |
0.0005 |
| 601 |
PETECHIAE |
5 |
0.0005 |
| 602 |
FEELING JITTERY |
9 |
0.0005 |
| 603 |
IMMUNODEFICIENCY |
7 |
0.0005 |
| 604 |
VITAMIN D DECREASED |
4 |
0.0005 |
| 605 |
SLEEP DISORDER |
33 |
0.0005 |
| 606 |
MALAISE |
204 |
0.0005 |
| 607 |
DRUG EFFECT DECREASED |
25 |
0.0005 |
| 608 |
MUSCLE STRAIN |
4 |
0.0005 |
| 609 |
HERPES SIMPLEX |
3 |
0.0005 |
| 610 |
PRODUCTIVE COUGH |
22 |
0.0005 |
| 611 |
SKIN LACERATION |
5 |
0.0005 |
| 612 |
NODULE |
6 |
0.0005 |
| 613 |
CLOSTRIDIUM DIFFICILE INFECTION |
10 |
0.0005 |
| 614 |
NAIL DISORDER |
4 |
0.0005 |
| 615 |
GASTRITIS |
12 |
0.0005 |
| 616 |
IMMUNE SYSTEM DISORDER |
6 |
0.0005 |
| 617 |
ANKYLOSING SPONDYLITIS |
6 |
0.0005 |
| 618 |
TOOTH INFECTION |
6 |
0.0005 |
| 619 |
HYPOGLYCAEMIA |
22 |
0.0005 |
| 620 |
UNDERDOSE |
33 |
0.0005 |
| 621 |
NEUROPATHY PERIPHERAL |
43 |
0.0005 |
| 622 |
DENTAL CARIES |
5 |
0.0005 |
| 623 |
SPINAL FRACTURE |
9 |
0.0004 |
| 624 |
GAIT INABILITY |
15 |
0.0004 |
| 625 |
THIRST |
8 |
0.0004 |
| 626 |
BRONCHIECTASIS |
3 |
0.0004 |
| 627 |
RASH |
194 |
0.0004 |
| 628 |
GASTROENTERITIS VIRAL |
8 |
0.0004 |
| 629 |
REBOUND EFFECT |
5 |
0.0004 |
| 630 |
LIP DRY |
4 |
0.0004 |
| 631 |
OBESITY |
7 |
0.0004 |
| 632 |
ANXIETY |
125 |
0.0004 |
| 633 |
SWELLING |
41 |
0.0004 |
| 634 |
DEPRESSED MOOD |
23 |
0.0004 |
| 635 |
DRY SKIN |
58 |
0.0004 |
| 636 |
PNEUMONIA |
140 |
0.0004 |
| 637 |
MUSCLE TIGHTNESS |
7 |
0.0004 |
| 638 |
INSOMNIA |
115 |
0.0004 |
| 639 |
EXTRASYSTOLES |
3 |
0.0004 |
| 640 |
TREMOR |
71 |
0.0004 |
| 641 |
BLOOD TEST ABNORMAL |
6 |
0.0004 |
| 642 |
ARTERIOSCLEROSIS |
4 |
0.0004 |
| 643 |
COVID-19 PNEUMONIA |
5 |
0.0004 |
| 644 |
BRONCHOSPASM |
6 |
0.0004 |
| 645 |
TREATMENT NONCOMPLIANCE |
23 |
0.0004 |
| 646 |
LIMB DISCOMFORT |
13 |
0.0004 |
| 647 |
DRUG DOSE OMISSION |
69 |
0.0004 |
| 648 |
DERMATITIS ATOPIC |
22 |
0.0004 |
| 649 |
LOWER LIMB FRACTURE |
8 |
0.0004 |
| 650 |
CRYING |
15 |
0.0004 |
| 651 |
SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION |
7 |
0.0004 |
| 652 |
BURSITIS |
5 |
0.0004 |
| 653 |
INTERVERTEBRAL DISC PROTRUSION |
9 |
0.0004 |
| 654 |
DYSSTASIA |
12 |
0.0004 |
| 655 |
HEAD INJURY |
13 |
0.0004 |
| 656 |
VITAMIN D DEFICIENCY |
4 |
0.0004 |
| 657 |
CHOKING |
8 |
0.0004 |
| 658 |
COELIAC DISEASE |
4 |
0.0004 |
| 659 |
KIDNEY INFECTION |
8 |
0.0004 |
| 660 |
DECREASED IMMUNE RESPONSIVENESS |
4 |
0.0004 |
| 661 |
THERAPY CHANGE |
4 |
0.0004 |
| 662 |
KNEE OPERATION |
4 |
0.0004 |
| 663 |
SMALL INTESTINAL OBSTRUCTION |
5 |
0.0004 |
| 664 |
URINARY INCONTINENCE |
12 |
0.0004 |
| 665 |
ECZEMA |
21 |
0.0004 |
| 666 |
SALIVARY HYPERSECRETION |
4 |
0.0004 |
| 667 |
IRRITABILITY |
24 |
0.0004 |
| 668 |
BREAST TENDERNESS |
3 |
0.0004 |
| 669 |
DIVERTICULITIS |
11 |
0.0004 |
| 670 |
EMPHYSEMA |
4 |
0.0004 |
| 671 |
LYMPHADENOPATHY |
14 |
0.0004 |
| 672 |
CONTUSION |
38 |
0.0004 |
| 673 |
INFLUENZA |
44 |
0.0004 |
| 674 |
NAUSEA |
311 |
0.0004 |
| 675 |
SLUGGISHNESS |
4 |
0.0004 |
| 676 |
HIP ARTHROPLASTY |
6 |
0.0004 |
| 677 |
DYSPHAGIA |
37 |
0.0004 |
| 678 |
SKIN DISORDER |
13 |
0.0004 |
| 679 |
OSTEOPOROSIS |
16 |
0.0004 |
| 680 |
LYMPHOMA |
6 |
0.0004 |
| 681 |
LUNG DISORDER |
19 |
0.0004 |
| 682 |
TEMPERATURE INTOLERANCE |
4 |
0.0004 |
| 683 |
TENDONITIS |
6 |
0.0004 |
| 684 |
POOR VENOUS ACCESS |
4 |
0.0004 |
| 685 |
AMNESIA |
25 |
0.0004 |
| 686 |
RESPIRATORY TRACT INFECTION |
10 |
0.0004 |
| 687 |
HEART RATE INCREASED |
38 |
0.0004 |
| 688 |
GASTROINTESTINAL INFLAMMATION |
3 |
0.0004 |
| 689 |
ROAD TRAFFIC ACCIDENT |
16 |
0.0004 |
| 690 |
INCORRECT DOSE ADMINISTERED BY DEVICE |
10 |
0.0004 |
| 691 |
MUSCLE SPASMS |
70 |
0.0004 |
| 692 |
URINARY TRACT INFECTION |
65 |
0.0004 |
| 693 |
SARS-COV-2 TEST POSITIVE |
5 |
0.0004 |
| 694 |
THERAPY NON-RESPONDER |
17 |
0.0004 |
| 695 |
CYSTITIS |
12 |
0.0004 |
| 696 |
ATRIAL FLUTTER |
3 |
0.0004 |
| 697 |
BREAST CANCER METASTATIC |
4 |
0.0004 |
| 698 |
OFF LABEL USE |
326 |
0.0004 |
| 699 |
PRODUCT USE IN UNAPPROVED INDICATION |
92 |
0.0004 |
| 700 |
FRACTURE |
7 |
0.0004 |
| 701 |
RASH PRURITIC |
20 |
0.0004 |
| 702 |
RESPIRATORY DISORDER |
11 |
0.0004 |
| 703 |
HERPES ZOSTER |
21 |
0.0004 |
| 704 |
HYPERAESTHESIA |
3 |
0.0004 |
| 705 |
ESCHERICHIA INFECTION |
3 |
0.0004 |
| 706 |
APPLICATION SITE PAIN |
8 |
0.0004 |
| 707 |
SPEECH DISORDER |
19 |
0.0004 |
| 708 |
RHEUMATOID ARTHRITIS |
41 |
0.0004 |
| 709 |
TOOTH DISORDER |
8 |
0.0004 |
| 710 |
FEELING HOT |
22 |
0.0004 |
| 711 |
HAEMORRHOIDS |
7 |
0.0004 |
| 712 |
SKIN REACTION |
5 |
0.0004 |
| 713 |
HAEMATOCRIT DECREASED |
7 |
0.0004 |
| 714 |
NEPHROLITHIASIS |
16 |
0.0003 |
| 715 |
HYPERTHYROIDISM |
5 |
0.0003 |
| 716 |
ASTHMA |
39 |
0.0003 |
| 717 |
NEEDLE ISSUE |
10 |
0.0003 |
| 718 |
RASH MACULAR |
12 |
0.0003 |
| 719 |
BLOOD CALCIUM INCREASED |
3 |
0.0003 |
| 720 |
GRIP STRENGTH DECREASED |
3 |
0.0003 |
| 721 |
PAIN IN EXTREMITY |
100 |
0.0003 |
| 722 |
BLOOD IRON DECREASED |
4 |
0.0003 |
| 723 |
POLLAKIURIA |
14 |
0.0003 |
| 724 |
PULMONARY MASS |
5 |
0.0003 |
| 725 |
HYPERLIPIDAEMIA |
4 |
0.0003 |
| 726 |
GASTROINTESTINAL INFECTION |
3 |
0.0003 |
| 727 |
KNEE ARTHROPLASTY |
7 |
0.0003 |
| 728 |
MOUTH ULCERATION |
7 |
0.0003 |
| 729 |
ALOPECIA |
65 |
0.0003 |
| 730 |
NOCTURIA |
4 |
0.0003 |
| 731 |
OSTEOPENIA |
5 |
0.0003 |
| 732 |
RETCHING |
7 |
0.0003 |
| 733 |
DIABETES MELLITUS |
25 |
0.0003 |
| 734 |
GLOMERULAR FILTRATION RATE DECREASED |
4 |
0.0003 |
| 735 |
BONE PAIN |
19 |
0.0003 |
| 736 |
MUSCULOSKELETAL CHEST PAIN |
5 |
0.0003 |
| 737 |
FEMUR FRACTURE |
10 |
0.0003 |
| 738 |
CYST |
4 |
0.0003 |
| 739 |
BLOOD CHOLESTEROL INCREASED |
15 |
0.0003 |
| 740 |
APPLICATION SITE IRRITATION |
4 |
0.0003 |
| 741 |
SKIN BURNING SENSATION |
23 |
0.0003 |
| 742 |
DEFORMITY |
3 |
0.0003 |
| 743 |
GAIT DISTURBANCE |
61 |
0.0003 |
| 744 |
PAIN IN JAW |
9 |
0.0003 |
| 745 |
CELLULITIS |
16 |
0.0003 |
| 746 |
INFUSION RELATED REACTION |
21 |
0.0003 |
| 747 |
BLOOD URINE PRESENT |
6 |
0.0003 |
| 748 |
DISEASE RECURRENCE |
15 |
0.0003 |
| 749 |
DYSPNOEA |
178 |
0.0003 |
| 750 |
HYPERSOMNIA |
9 |
0.0003 |
| 751 |
HYPOTHYROIDISM |
10 |
0.0003 |
| 752 |
INJURY |
22 |
0.0003 |
| 753 |
HYPOPHAGIA |
8 |
0.0003 |
| 754 |
PARAESTHESIA |
49 |
0.0003 |
| 755 |
CARDIAC DISORDER |
29 |
0.0003 |
| 756 |
RASH GENERALISED |
8 |
0.0003 |
| 757 |
MUSCULOSKELETAL STIFFNESS |
27 |
0.0003 |
| 758 |
BLOOD PRESSURE SYSTOLIC INCREASED |
6 |
0.0003 |
| 759 |
DEATH |
264 |
0.0003 |
| 760 |
BEDRIDDEN |
4 |
0.0003 |
| 761 |
INFECTION |
44 |
0.0003 |
| 762 |
WHEEZING |
18 |
0.0003 |
| 763 |
FATIGUE |
236 |
0.0003 |
| 764 |
CONSTIPATION |
66 |
0.0003 |
| 765 |
HYPERTENSION |
64 |
0.0003 |
| 766 |
PANIC ATTACK |
11 |
0.0003 |
| 767 |
PSYCHOMOTOR HYPERACTIVITY |
5 |
0.0003 |
| 768 |
ABDOMINAL PAIN UPPER |
62 |
0.0003 |
| 769 |
HYPOAESTHESIA |
45 |
0.0003 |
| 770 |
FLATULENCE |
17 |
0.0003 |
| 771 |
HOSPITALISATION |
46 |
0.0003 |
| 772 |
MUSCULAR WEAKNESS |
34 |
0.0003 |
| 773 |
MALIGNANT MELANOMA |
4 |
0.0003 |
| 774 |
JOINT RANGE OF MOTION DECREASED |
4 |
0.0003 |
| 775 |
EMOTIONAL DISTRESS |
36 |
0.0003 |
| 776 |
BACK PAIN |
69 |
0.0003 |
| 777 |
THERAPEUTIC RESPONSE DECREASED |
18 |
0.0003 |
| 778 |
FEEDING DISORDER |
6 |
0.0003 |
| 779 |
PRODUCT SUBSTITUTION ISSUE |
17 |
0.0003 |
| 780 |
BODY TEMPERATURE INCREASED |
6 |
0.0003 |
| 781 |
RASH ERYTHEMATOUS |
14 |
0.0003 |
| 782 |
DEHYDRATION |
39 |
0.0003 |
| 783 |
BLOOD PRESSURE FLUCTUATION |
7 |
0.0003 |
| 784 |
RESPIRATORY DISTRESS |
8 |
0.0003 |
| 785 |
PROCEDURAL PAIN |
8 |
0.0003 |
| 786 |
MASS |
4 |
0.0003 |
| 787 |
FOLLICULITIS |
3 |
0.0003 |
| 788 |
PERIPHERAL SWELLING |
44 |
0.0003 |
| 789 |
COLD SWEAT |
5 |
0.0003 |
| 790 |
FULL BLOOD COUNT ABNORMAL |
3 |
0.0003 |
| 791 |
BLOOD TRIGLYCERIDES INCREASED |
5 |
0.0003 |
| 792 |
IMPAIRED WORK ABILITY |
6 |
0.0003 |
| 793 |
HEREDITARY ANGIOEDEMA |
3 |
0.0003 |
| 794 |
POOR QUALITY SLEEP |
6 |
0.0003 |
| 795 |
DISTURBANCE IN ATTENTION |
15 |
0.0003 |
| 796 |
PRURITUS GENERALISED |
6 |
0.0003 |
| 797 |
CEREBROVASCULAR ACCIDENT |
47 |
0.0003 |
| 798 |
BIPOLAR DISORDER |
3 |
0.0003 |
| 799 |
STAPHYLOCOCCAL INFECTION |
9 |
0.0003 |
| 800 |
GASTROINTESTINAL PAIN |
3 |
0.0003 |
| 801 |
ARTHRALGIA |
113 |
0.0003 |
| 802 |
DIARRHOEA |
175 |
0.0003 |
| 803 |
COLON CANCER |
4 |
0.0003 |
| 804 |
MIDDLE INSOMNIA |
5 |
0.0003 |
| 805 |
TRANSIENT ISCHAEMIC ATTACK |
9 |
0.0003 |
| 806 |
FLUSHING |
27 |
0.0003 |
| 807 |
MUSCULOSKELETAL DISORDER |
5 |
0.0003 |
| 808 |
DRUG ADMINISTRATION ERROR |
8 |
0.0003 |
| 809 |
DRUG PRESCRIBING ERROR |
5 |
0.0003 |
| 810 |
PAIN OF SKIN |
7 |
0.0003 |
| 811 |
HERNIA |
5 |
0.0003 |
| 812 |
ERUCTATION |
5 |
0.0003 |
| 813 |
EXPOSURE DURING PREGNANCY |
16 |
0.0003 |
| 814 |
JOINT SWELLING |
31 |
0.0003 |
| 815 |
HYPOXIA |
9 |
0.0003 |
| 816 |
ABNORMAL DREAMS |
7 |
0.0003 |
| 817 |
ARTHROPATHY |
14 |
0.0003 |
| 818 |
WEIGHT DECREASED |
70 |
0.0003 |
| 819 |
INJECTION SITE BRUISING |
20 |
0.0003 |
| 820 |
DEPRESSION |
57 |
0.0003 |
| 821 |
SENSORY DISTURBANCE |
4 |
0.0002 |
| 822 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
13 |
0.0002 |
| 823 |
THROMBOSIS |
20 |
0.0002 |
| 824 |
NIGHT SWEATS |
8 |
0.0002 |
| 825 |
MULTIPLE FRACTURES |
4 |
0.0002 |
| 826 |
LETHARGY |
14 |
0.0002 |
| 827 |
COAGULOPATHY |
4 |
0.0002 |
| 828 |
BLOOD UREA INCREASED |
4 |
0.0002 |
| 829 |
LABORATORY TEST ABNORMAL |
7 |
0.0002 |
| 830 |
FLUID RETENTION |
12 |
0.0002 |
| 831 |
ARRHYTHMIA |
11 |
0.0002 |
| 832 |
INCORRECT PRODUCT ADMINISTRATION DURATION |
5 |
0.0002 |
| 833 |
MULTIPLE SCLEROSIS |
11 |
0.0002 |
| 834 |
ORTHOSTATIC HYPOTENSION |
4 |
0.0002 |
| 835 |
APPLICATION SITE ERYTHEMA |
6 |
0.0002 |
| 836 |
ABDOMINAL PAIN |
53 |
0.0002 |
| 837 |
HEART RATE DECREASED |
8 |
0.0002 |
| 838 |
DEVICE DIFFICULT TO USE |
15 |
0.0002 |
| 839 |
LOSS OF CONSCIOUSNESS |
29 |
0.0002 |
| 840 |
ATRIAL FIBRILLATION |
22 |
0.0002 |
| 841 |
HOT FLUSH |
17 |
0.0002 |
| 842 |
HAIR TEXTURE ABNORMAL |
3 |
0.0002 |
| 843 |
MOBILITY DECREASED |
16 |
0.0002 |
| 844 |
PSORIASIS |
29 |
0.0002 |
| 845 |
MOOD ALTERED |
6 |
0.0002 |
| 846 |
DECREASED APPETITE |
51 |
0.0002 |
| 847 |
INFLUENZA LIKE ILLNESS |
18 |
0.0002 |
| 848 |
ANAPHYLACTIC REACTION |
12 |
0.0002 |
| 849 |
HYPOMAGNESAEMIA |
3 |
0.0002 |
| 850 |
HUNGER |
3 |
0.0002 |
| 851 |
HAEMOPTYSIS |
6 |
0.0002 |
| 852 |
COGNITIVE DISORDER |
10 |
0.0002 |
| 853 |
DEVICE OCCLUSION |
3 |
0.0002 |
| 854 |
HALLUCINATION |
16 |
0.0002 |
| 855 |
INTESTINAL OBSTRUCTION |
8 |
0.0002 |
| 856 |
HYPOCALCAEMIA |
4 |
0.0002 |
| 857 |
PULMONARY FIBROSIS |
4 |
0.0002 |
| 858 |
TYPE 2 DIABETES MELLITUS |
7 |
0.0002 |
| 859 |
PRESCRIBED OVERDOSE |
4 |
0.0002 |
| 860 |
HYPOKINESIA |
3 |
0.0002 |
| 861 |
CONFUSIONAL STATE |
33 |
0.0002 |
| 862 |
GASTRIC DISORDER |
7 |
0.0002 |
| 863 |
DISORIENTATION |
8 |
0.0002 |
| 864 |
CHEST PAIN |
37 |
0.0002 |
| 865 |
ASTHENIA |
75 |
0.0002 |
| 866 |
GLYCOSYLATED HAEMOGLOBIN INCREASED |
5 |
0.0002 |
| 867 |
HEPATITIS |
5 |
0.0002 |
| 868 |
EMOTIONAL DISORDER |
6 |
0.0002 |
| 869 |
TOOTH LOSS |
4 |
0.0002 |
| 870 |
BASAL CELL CARCINOMA |
3 |
0.0002 |
| 871 |
HEPATIC ENZYME INCREASED |
13 |
0.0002 |
| 872 |
JOINT STIFFNESS |
5 |
0.0002 |
| 873 |
ABSCESS |
3 |
0.0002 |
| 874 |
CHILLS |
22 |
0.0002 |
| 875 |
WEIGHT INCREASED |
42 |
0.0002 |
| 876 |
SKIN CANCER |
4 |
0.0002 |
| 877 |
BLOOD POTASSIUM INCREASED |
3 |
0.0002 |
| 878 |
OEDEMA |
10 |
0.0002 |
| 879 |
DEVICE DELIVERY SYSTEM ISSUE |
5 |
0.0002 |
| 880 |
SKIN LESION |
5 |
0.0002 |
| 881 |
TACHYCARDIA |
16 |
0.0002 |
| 882 |
PULMONARY EMBOLISM |
17 |
0.0002 |
| 883 |
CHROMATURIA |
4 |
0.0002 |
| 884 |
AGITATION |
13 |
0.0002 |
| 885 |
MYALGIA |
30 |
0.0002 |
| 886 |
RED BLOOD CELL COUNT DECREASED |
5 |
0.0002 |
| 887 |
PERICARDIAL EFFUSION |
4 |
0.0002 |
| 888 |
ABDOMINAL DISTENSION |
18 |
0.0002 |
| 889 |
DRUG EFFECTIVE FOR UNAPPROVED INDICATION |
5 |
0.0002 |
| 890 |
PYREXIA |
59 |
0.0002 |
| 891 |
SYNCOPE |
17 |
0.0002 |
| 892 |
GALLBLADDER DISORDER |
3 |
0.0002 |
| 893 |
VOMITING |
79 |
0.0002 |
| 894 |
BLOOD PRESSURE DECREASED |
11 |
0.0002 |
| 895 |
PRESYNCOPE |
4 |
0.0002 |
| 896 |
HAEMATOCHEZIA |
9 |
0.0002 |
| 897 |
MENTAL DISORDER |
7 |
0.0002 |
| 898 |
MYOCARDIAL INFARCTION |
28 |
0.0002 |
| 899 |
HEPATIC CIRRHOSIS |
3 |
0.0002 |
| 900 |
GASTRIC ULCER |
3 |
0.0002 |
| 901 |
HAEMATEMESIS |
4 |
0.0002 |
| 902 |
SUICIDAL IDEATION |
14 |
0.0002 |
| 903 |
HYPOKALAEMIA |
7 |
0.0002 |
| 904 |
BREAST CANCER |
14 |
0.0002 |
| 905 |
URINARY RETENTION |
5 |
0.0001 |
| 906 |
BLOOD GLUCOSE INCREASED |
28 |
0.0001 |
| 907 |
ANGER |
5 |
0.0001 |
| 908 |
DYSKINESIA |
6 |
0.0001 |
| 909 |
MULTIPLE SCLEROSIS RELAPSE |
10 |
0.0001 |
| 910 |
DRUG INTERACTION |
23 |
0.0001 |
| 911 |
FEELING COLD |
4 |
0.0001 |
| 912 |
WOUND |
4 |
0.0001 |
| 913 |
OXYGEN SATURATION DECREASED |
8 |
0.0001 |
| 914 |
HALLUCINATION, VISUAL |
3 |
0.0001 |
| 915 |
HYPERHIDROSIS |
18 |
0.0001 |
| 916 |
ANGINA PECTORIS |
4 |
0.0001 |
| 917 |
SEIZURE |
16 |
0.0001 |
| 918 |
C-REACTIVE PROTEIN INCREASED |
5 |
0.0001 |
| 919 |
RESTLESSNESS |
5 |
0.0001 |
| 920 |
ANGIOEDEMA |
6 |
0.0001 |
| 921 |
LIVER DISORDER |
6 |
0.0001 |
| 922 |
SEPSIS |
15 |
0.0001 |
| 923 |
COLITIS ULCERATIVE |
6 |
0.0001 |
| 924 |
MUSCULOSKELETAL PAIN |
7 |
0.0001 |
| 925 |
DYSARTHRIA |
5 |
0.0001 |
| 926 |
APPLICATION SITE PRURITUS |
3 |
0.0001 |
| 927 |
LOWER RESPIRATORY TRACT INFECTION |
6 |
0.0001 |
| 928 |
COLITIS |
5 |
0.0001 |
| 929 |
INJECTION SITE RASH |
4 |
0.0001 |
| 930 |
WHITE BLOOD CELL COUNT INCREASED |
5 |
0.0001 |
| 931 |
SOMNOLENCE |
26 |
0.0001 |
| 932 |
RENAL DISORDER |
6 |
0.0001 |
| 933 |
INJECTION SITE HAEMORRHAGE |
10 |
0.0001 |
| 934 |
HYPOTENSION |
25 |
0.0001 |
| 935 |
MOVEMENT DISORDER |
4 |
0.0001 |
| 936 |
CARDIAC FAILURE CONGESTIVE |
10 |
0.0001 |
| 937 |
MATERNAL EXPOSURE DURING PREGNANCY |
11 |
0.0001 |
| 938 |
DEVICE ISSUE |
11 |
0.0001 |
| 939 |
BLOOD CREATININE INCREASED |
8 |
0.0001 |
| 940 |
ACNE |
9 |
0.0001 |
| 941 |
INJECTION SITE PAIN |
36 |
0.0001 |
| 942 |
HAEMOGLOBIN DECREASED |
12 |
0.0001 |
| 943 |
ERECTILE DYSFUNCTION |
3 |
0.0001 |
| 944 |
ANAPHYLACTIC SHOCK |
3 |
0.0001 |
| 945 |
NIGHTMARE |
4 |
0.0001 |
| 946 |
ANAEMIA |
22 |
0.0001 |
| 947 |
HAEMORRHAGE |
12 |
0.0001 |
| 948 |
FREQUENT BOWEL MOVEMENTS |
3 |
0.0001 |
| 949 |
DRUG EFFECT INCOMPLETE |
4 |
0.0001 |
| 950 |
HYPERGLYCAEMIA |
4 |
0.0001 |
| 951 |
INTENTIONAL OVERDOSE |
7 |
0.0001 |
| 952 |
DYSURIA |
4 |
0.0001 |
| 953 |
INCORRECT DRUG ADMINISTRATION DURATION |
3 |
0.0001 |
| 954 |
DYSPNOEA EXERTIONAL |
4 |
0.0001 |
| 955 |
INJECTION SITE SWELLING |
8 |
0.0001 |
| 956 |
BLOOD GLUCOSE DECREASED |
5 |
0.0001 |
| 957 |
ACUTE MYOCARDIAL INFARCTION |
3 |
0.0001 |
| 958 |
INJECTION SITE REACTION |
7 |
0.0001 |
| 959 |
BLOOD POTASSIUM DECREASED |
3 |
0.0001 |
| 960 |
APHASIA |
3 |
0.0001 |
| 961 |
CONTRAINDICATED PRODUCT ADMINISTERED |
3 |
0.0001 |
| 962 |
BONE DENSITY DECREASED |
3 |
0.0001 |
| 963 |
WITHDRAWAL SYNDROME |
4 |
0.0001 |
| 964 |
RECTAL HAEMORRHAGE |
4 |
0.0001 |
| 965 |
CHOLELITHIASIS |
3 |
0.0001 |
| 966 |
DEVICE USE ERROR |
3 |
0.0001 |
| 967 |
DEVICE MALFUNCTION |
6 |
0.0001 |
| 968 |
CEREBRAL HAEMORRHAGE |
3 |
0.0001 |
| 969 |
ALANINE AMINOTRANSFERASE INCREASED |
5 |
0.0001 |
| 970 |
GENERAL PHYSICAL HEALTH DETERIORATION |
9 |
0.0001 |
| 971 |
DISEASE PROGRESSION |
9 |
0.0001 |
| 972 |
ASPARTATE AMINOTRANSFERASE INCREASED |
4 |
0.0001 |
| 973 |
CARDIAC FAILURE |
6 |
0.0001 |
| 974 |
INJECTION SITE PRURITUS |
5 |
0.0001 |
| 975 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
4 |
0.0001 |
| 976 |
INJECTION SITE ERYTHEMA |
9 |
0.0001 |
| 977 |
ACUTE KIDNEY INJURY |
11 |
0.0001 |
| 978 |
RENAL IMPAIRMENT |
6 |
0.0001 |
| 979 |
DEVICE LEAKAGE |
3 |
0.0001 |
| 980 |
CHRONIC KIDNEY DISEASE |
5 |
0.0001 |
| 981 |
PLEURAL EFFUSION |
4 |
0.0001 |
| 982 |
OEDEMA PERIPHERAL |
8 |
0.0001 |
| 983 |
HYPONATRAEMIA |
3 |
0.0001 |
| 984 |
BLADDER CANCER |
3 |
0.0001 |
| 985 |
GASTROINTESTINAL HAEMORRHAGE |
4 |
0.0000 |
| 986 |
RENAL FAILURE |
6 |
0.0000 |
| 987 |
TOXICITY TO VARIOUS AGENTS |
7 |
0.0000 |
| 988 |
THROMBOCYTOPENIA |
4 |
0.0000 |